Carigent Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 3

Carigent Therapeutics General Information

Description

Developer of drug delivery technology designed to optimize delivery and controlled release of therapeutic and diagnostic agents into diseased tissues and cells. The company's technology is based on novel nanotechnology that provides the unique capability of tethering biological targeting agents at unprecedented densities to the surface of biodegradable polymer nanoparticles, enabling drugs to remain in the bloodstream longer than other nanotechnology-based drugs.

Contact Information

Website
www.carigent.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5 Science Park
  • Suite 13
  • New Haven, CT 06520
  • United States
+1 (203)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Therapeutic Devices
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 5 Science Park
  • Suite 13
  • New Haven, CT 06520
  • United States
+1 (203)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carigent Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Carigent Therapeutics‘s full profile, request access.

Request a free trial

Carigent Therapeutics FAQs

  • When was Carigent Therapeutics founded?

    Carigent Therapeutics was founded in 2007.

  • Where is Carigent Therapeutics headquartered?

    Carigent Therapeutics is headquartered in New Haven, CT.

  • What industry is Carigent Therapeutics in?

    Carigent Therapeutics’s primary industry is Biotechnology.

  • Is Carigent Therapeutics a private or public company?

    Carigent Therapeutics is a Private company.

  • What is Carigent Therapeutics’s current revenue?

    The current revenue for Carigent Therapeutics is .

  • How much funding has Carigent Therapeutics raised over time?

    Carigent Therapeutics has raised $3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »